Hallo,

es gibt eine kleine Studie mit 98 Patienten, in der R1 und R2 gegen eine Standardbehandlung mit harnstoffhaltiger Creme getestet wurde.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485614/

Treatment with R1 and R2 significantly reduced the grade of radiation dermatitis in patients treated with chemoradiotherapy. At the fourth (last) clinic visit, at 2 weeks following the end of radiation treatment, 66.7% of patients in the treated group (R1 and R2) were free from radiation dermatitis compared with 34% in those given the center’s usual skin care (topical urea lotion). There were no reported side effects, and quality of life improved for patients treated with R1 and R2

Viele Grüße
Karl